Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
79.98
-1.58 (-1.94%)
Nov 17, 2026, 3:00 PM CST

SHA:688578 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,122674.54586.991,862470.49615.36
Short-Term Investments
-360280230-20
Trading Asset Securities
2,6742,5112,759419.61,5671,625
Cash & Short-Term Investments
3,7963,5463,6262,5122,0372,260
Cash Growth
15.79%-2.23%44.37%23.29%-9.86%-12.78%
Accounts Receivable
490.97375.6389260.17150.8514.83
Other Receivables
18.0845.3529.2629.076.823.58
Receivables
509.05420.96418.26289.24157.6818.42
Inventory
78.4871.6630.5662.9532.0720.8
Prepaid Expenses
----2.5-
Other Current Assets
621.27132.13105.3643.9756.6975.42
Total Current Assets
5,0054,1704,1802,9082,2862,375
Property, Plant & Equipment
496.41516.92516.37526.64539.94404.03
Long-Term Investments
260.28180.49244.4145.2652.7338.37
Other Intangible Assets
165.05175.2365.3866.4968.4567.29
Long-Term Deferred Tax Assets
0-0-11.5-
Long-Term Deferred Charges
227.45176.46168.120.710.572.11
Other Long-Term Assets
3,9032,685741.45729.5482.76243.79
Total Assets
10,0577,9055,9164,3763,4423,130

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
151.1813.1127.3913.255.151.75
Accrued Expenses
270.12663.25482.4314.33152.6896.96
Current Portion of Leases
1.91.870.991.431.664.72
Current Income Taxes Payable
269.19101.9867.455.46.98-
Current Unearned Revenue
7.744.21--0.10.18
Other Current Liabilities
387.7221.222.3755.6288.0452.51
Total Current Liabilities
1,088805.62600.6390.03254.62156.12
Long-Term Leases
1.72.010.30.390.30.68
Long-Term Deferred Tax Liabilities
18.1710.5728.770.14--
Other Long-Term Liabilities
0.223.273.653.650.20.2
Total Liabilities
1,108821.48633.32394.22255.12156.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
450450450450450450
Additional Paid-In Capital
3,2843,2793,2543,1753,1003,031
Retained Earnings
5,0243,2301,401264.02-380.16-510.68
Comprehensive Income & Other
191.39123.57177.8993.6317.613.25
Shareholders' Equity
8,9497,0835,2833,9823,1872,973
Total Liabilities & Equity
10,0577,9055,9164,3763,4423,130

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3.613.891.31.821.965.39
Net Cash (Debt)
3,7933,5423,6252,5102,0352,255
Net Cash Growth
15.81%-2.30%44.42%23.32%-9.73%-12.99%
Net Cash Per Share
8.437.868.065.574.524.94
Filing Date Shares Outstanding
450450450450450450
Total Common Shares Outstanding
450450450450450450
Working Capital
3,9173,3653,5802,5182,0322,219
Book Value Per Share
19.8915.7411.748.857.086.61
Tangible Book Value
8,7846,9085,2173,9163,1192,906
Tangible Book Value Per Share
19.5215.3511.598.706.936.46
Buildings
-489.01482.3494.91470.35116.73
Machinery
-214.95182.95132.04140.2788.34
Construction In Progress
-1.215.1918.5813.8266.57